Renaissance Capital logo

STDY News

US IPO Weekly Recap: 2 firms go public as a Birmingham bank bounds while med-tech misses

National Commerce raised $33 million and then the Birmingham bank bounded. Two small medical device companies struggled as SteadyMed had a shaky opening and another pushed its IPO to next week. IPO highlights during the week of March 16, 2015: ...read more

SteadyMed prices IPO at $8.50, below the range

SteadyMed, which is developing a proprietary pump system for the treatment of PAH and pain, raised $40 million by offering 4.7 million shares at $8.50, below the range of $12 to $14. SteadyMed will list on the NASDAQ under the symbol STDY. Wells Fargo...read more

Week ahead: 3 IPOs planned for the week of March 16

Three IPOs are expected to price this week - a pump, a pump replacement and a regional bank - though the combined proceeds will still fall short of ...read more

Pumped up IPOs: SteadyMed sets terms for $55 million IPO

SteadyMed, which is developing a combination therapy and pump for pulmonary disease and pain, announced terms for its IPO on Monday. The San Ramon, CA-based company plans to raise $55 million by offering 4.3 million shares at a price range of $12 to $14. At...read more